Neuronetics, Inc.

STIM ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016
Operating Activities
Net Income $-16.1M $-11.2M
Depreciation & Amortization $596.0K $673.0K
Depreciation
Amortization
Stock-Based Compensation $496.0K $161.0K
Net Cash from Operating Activities $-11.1M $-8.5M
Investing Activities
Capital Expenditures $594.0K $324.0K
Business Acquisitions
Net Cash from Investing Activities $-594.0K $-324.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $23.8M $4.9M
Net Change in Cash
Free Cash Flow $-11.7M $-8.9M
← Newer Page 2 of 2 Older →